On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Mark E. Cooper

ResearcherPublications, citations & collaboration network

Mark E. Cooper is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Mark E. Cooper have?

ScholarIQindexed works

Mark E. Cooper has 707 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Mark E. Cooper have?

ScholarIQcitation count

Mark E. Cooper has 73,774 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Mark E. Cooper?

ScholarIQh-index

Mark E. Cooper has an h-index of 124 in OpenAlex.

What is the i10-index of Mark E. Cooper?

ScholarIQi10-index

Mark E. Cooper has an i10-index of 438 in OpenAlex.

What is the ORCID of Mark E. Cooper?

ScholarIQorcid

The ORCID for Mark E. Cooper is on the source record.

What is the OpenAlex record for Mark E. Cooper?

ScholarIQopenalex

The OpenAlex for Mark E. Cooper is on the source record.

What are the most-cited papers on Mark E. Cooper?

ScholarIQmost cited works
Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy
Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw, William F. Keane, William E. Mitch, Hans‐Henrik Parving, Giuseppe Remuzzi, Steven Snapinn, Zhonxin Zhang, Shahnaz Shahinfar
New England Journal of Medicine. 20017,516 CitationsOPEN ACCESS
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
The ADVANCE Collaborative Group
New England Journal of Medicine. 20087,445 CitationsOPEN ACCESS
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
Marc A. Pfeffer, Emmanuel A. Burdmann, Chao Yin Chen, Mark E. Cooper, Dick de Zeeuw, Kai-Uwe Eckardt, Jan Feyzi, Peter Ivanovich, Reshma Kewalramani, Andrew S. Levey, Eldrin F. Lewis, Janet B. McGill, John J.V. McMurray, Patrick S. Parfrey, Hans Henrik Parving, Giuseppe Remuzzi, Ajay Singh, Scott D. Solomon, Robert D. Toto
New England Journal of Medicine. 20092,088 CitationsOPEN ACCESS
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Steven E. Kahn, Mark E. Cooper, Stefano Del Prato
The Lancet. 20131,759 Citations
Diabetic kidney disease
Merlin C. Thomas, Michael Brownlee, Katalin Suszták, Kumar Sharma, Karin Jandeleit‐Dahm, Sophia Zoungas, Peter Rossing, Per‐Henrik Groop, Mark E. Cooper
Nature Reviews Disease Primers. 20151,233 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account